These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 5755842

  • 1. [Treatment of coronary heart disease from the modern point of view].
    Dockweiler J.
    Arzneimittelforschung; 1968 Aug; 18(8):1081-4. PubMed ID: 5755842
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical experience with N,N'-dimethyl-N,N'-bis-(3-(3',4',5'-trimethoxybenzoyloxy)-propyl)-ethylenediamine dihydrochloride (hexobendine)].
    Zimmermann W.
    Arzneimittelforschung; 1968 Aug; 18(8):1112-4. PubMed ID: 5756048
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical trial of the new coronary dilator hexobendine].
    Henke C, Dudik E, Steim H.
    Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bicordin--a new drug in the treatment of coronary heart disease.
    Samochowiec L, Wójcicki J, Gregorczyk K, Szmatloch E.
    Mater Med Pol; 1974 Aug; 6(4):298-300. PubMed ID: 4453155
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical experiences with the use of carbochromen in coronary syndrome].
    Ivancić R, Persić T, Custović F.
    Arzneimittelforschung; 1970 Mar; 20():454-6. PubMed ID: 4916580
    [No Abstract] [Full Text] [Related]

  • 11. [Carbochromen in therapy of acute and chronic coronary insufficiency].
    Votcal BE, Lozinskij LG.
    Arzneimittelforschung; 1970 Mar; 20():459-60. PubMed ID: 4989254
    [No Abstract] [Full Text] [Related]

  • 12. Coronary vasoconstriction: where do we stand in 1999. An important, multifaceted but elusive role.
    Maseri A, Crea F, Lanza GA.
    Cardiologia; 1999 Feb; 44(2):115-8. PubMed ID: 10208047
    [No Abstract] [Full Text] [Related]

  • 13. [Ildamen in the treatment of coronary heart disease].
    Markiewicz M, Bielak J, Zminkowska U.
    Pol Tyg Lek; 1972 Jul 24; 27(30):1176-8. PubMed ID: 5073030
    [No Abstract] [Full Text] [Related]

  • 14. Hemodynamic and therapeutic effect of BAY a 1040 on the patients with ischemic heart disease.
    Hayase S, Hirakawa S, Hosokawa S, Mori N, Kanyama S.
    Arzneimittelforschung; 1972 Feb 24; 22(2):370-3. PubMed ID: 4554632
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of severe coronary insufficiency with carbochromen].
    Friese G.
    Arzneimittelforschung; 1970 Mar 24; 20():451-3. PubMed ID: 5468730
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Electrocardiographic studies on the drug Clinium].
    Széplaki S, Böszörményi E, Werkner J, Szmandra J.
    Orv Hetil; 1974 Jan 06; 115(1):25-8. PubMed ID: 4809138
    [No Abstract] [Full Text] [Related]

  • 18. [Use of carbochromen in coronary insufficiency].
    Kobaladze SG, Saginjan VS, Sonija GS, Masasvili LS, Celisvili NV.
    Arzneimittelforschung; 1970 Mar 06; 20():468-9. PubMed ID: 5468734
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.